UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(CHECK ONE): ( ) Form 10-K ( ) Form 20-F ( ) Form 11-K (X) Form 10-Q
( ) Form N-SAR
For Period Ended: September 30, 2004
------------------
( ) Transition Report on Form 10-K
( ) Transition Report on Form 20-F
( ) Transition Report on Form 11-K
( ) Transition Report on Form 10-Q
( ) Transition Report on Form N-SAR
For the Transition Period Ended:
------------------------------
Read instruction (on back page) before preparing form. Please print or type.
Nothing in this form shall be construed to imply that the commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
----------------------------------
PART I -- REGISTRANT INFORMATION
Full Name of Registrant: Coram Healthcare Corporation
-----------------------------------------------------
Former Name if Applicable: None
-----------------------------------------------------
Address of Principal Executive Office (Street and Number): 1675 Broadway,
Suite 900
--------------------
City, State and Zip Code: Denver, Colorado 80202
-----------------------------------------------------
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(X) (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(X) (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or
transition report on Form 10-Q, or portion thereof, will be filed on or
before the fifth calendar day following the prescribed due date;
( ) (c) The accountants statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N-SAR, or the transition report portion thereof, could not be filed within
the prescribed time period. (Attach extra sheets if needed.)
Coram Healthcare Corporation ("Coram") requires additional time to
complete its Form 10-Q for the quarterly period ended September 30, 2004 as a
result of management's involvement with activities relating to certain filings
of voluntary petitions under Chapter 11 of Title 11 of the United States Code on
August 8, 2000. Coram will file its Form 10-Q on or before Friday November 19,
2004.
(1) Name and telephone number of person to contact in regard to this
notification:
Scott R. Danitz 800 267-2642
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report been filed? If the answer is no,
identify report(s).
(X) Yes ( ) No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
(X) Yes ( ) No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Based on information currently available, management believes that the
company's provision for estimated uncollectible accounts for the three months
ended September 30, 2004 will be approximately $7.0 million (i.e., an increase
of $2.3 million over the corresponding period in the prior year). Moreover, net
reorganization expenses will approximate $1.5 million for the three months ended
September 30, 2004 (i.e., a decrease of $3.9 million from the same period in the
prior year). Management projects that Coram will report net income for the three
months ended September 30, 2004 of approximately $5.0 million (i.e., basic and
diluted net income per
-2-
common share of $0.10). The amounts discussed herein are subject to change upon
the filing of Coram's Form 10-Q.
Coram Healthcare Corporation has caused this notification to be signed on its
behalf by the undersigned thereunto duly authorized.
Date: November 15, 2004 By: /s/ SCOTT R. DANITZ
------------------------------ -------------------------------------
Name: Scott R. Danitz
Title: Senior Vice President, Chief
Financial Officer, Treasurer &
Principal Accounting Officer
Instruction. The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
--------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules
and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange Commission,
Washington, D.C. 20549, in accordance with Rule O-3 of the General Rules and
Regulations under the Act. The information contained in or filed with the form
will be made a matter of public record in the Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed with
each national securities exchange on which any class of securities of the
registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but need
not restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
5. Electronic Filers. This form shall not be used by electronic filers unable to
timely file a report solely due to electronic difficulties. Filers unable to
submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of Regulation
S-T (Section 232.201 or Section 232.202 of this chapter) or apply for an
adjustment in filing date pursuant to Rule 13(b) of Regulation S-T (Section
232.13(b) of this chapter).
-3-